Skip to main content

Smith-Van Vurst Andrew's Form 4 filing

BioStem Technologies, Inc. (BSEM) · filed Sep 17, 2026

Accession no.
0001193125-26-394391
Filed
Sep 17, 2026, 4:30 PM ET
Trade date
Sep 15-17, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Smith-Van Vurst AndrewCIK 0002147206Director, Officer (Chief Operating Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2026Common StockMOption exerciseAcquired+7,622$0.00$01,530,235Direct
Sep 17, 2026Common StockMOption exerciseAcquired+9,574$0.00$01,539,809Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 15, 2026Common StockMOption exerciseDisposed−7,622$0.00$030,487Direct
Sep 17, 2026Common StockMOption exerciseDisposed−9,574$0.00$057,442Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Exhibit 24 - Power of Attorney

Read the full filing on SEC EDGAR (opens in a new tab)